Tecemotide in unresectable stage III non-small-cell lung cancer in the phase III START study: updated overall survival and biomarker analyses. WoS Publication

cited authors

  • Mitchell, P; Thatcher, N; Socinski, M A; Wasilewska-Tesluk, E; Horwood, K; Szczesna, A; Martin, C; Ragulin, Y; Zukin, M; Helwig, C; Falk, M; Butts, C; Shepherd, F A

authors

Publication Date

  • June 1, 2015

webpage

published in

category

start page

  • 1134

end page

  • 1142

volume

  • 26

issue

  • 6